文献速递肿瘤 PET/CT骨显像与常规 SPECT

99mTc-PSMA SPECT/CT 显像发现前列腺腺癌输精管复发

Prostate Adenocarcinoma Recurrence in the Vas Deferens Unveiled by 99m Tc-PSMA SPECT/CT Imaging.
PubMed 文献 · Clin Nucl Med · 2025-05-08

本文报告一例77岁前列腺癌患者,根治性前列腺切除术后切缘阴性,10年未随访后血清前列腺特异性抗原升至2.76 ng/mL提示复发;因68Ga-PSMA PET/CT可及性有限,行99mTc-HYNIC-PSMA SPECT/CT,发现双侧输精管PSMA摄取,为罕见复发部位。

要点

  • 77岁前列腺癌根治术后切缘阴性患者,10年未随访后PSA升至2.76 ng/mL提示复发。
  • 因68Ga-PSMA PET/CT可及性有限,行99mTc-HYNIC-PSMA SPECT/CT发现双侧输精管PSMA摄取。
  • 输精管复发此前曾用68Ga-PSMA PET/CT或PET/MR报告,99mTc-PSMA SPECT/CT为新增经验。

核心结论

  • 99mTc-PSMA SPECT/CT在此例中检出了双侧输精管PSMA摄取这一罕见复发部位,作者认为该显像在PET/CT可及性有限地区具有潜在价值。

研究设计与样本

  • 本文为个案报告,对象为1例77岁前列腺癌根治性切除术后切缘阴性的患者。

主要发现

  • 患者术后10年未随访,血清前列腺特异性抗原升至2.76 ng/mL,提示疾病复发。
  • 因68Ga-PSMA PET/CT可及性有限,行99mTc-HYNIC-PSMA SPECT/CT,显示双侧输精管PSMA摄取。

关键数值与推荐

  • 血清前列腺特异性抗原为2.76 ng/mL。
  • 输精管复发此前已有使用68Ga-PSMA PET/CT或PET/MR的报道。

临床怎么用

  • 作者认为99mTc-PSMA SPECT/CT在检测此类复发方面具有潜在用途,尤其在PET/CT可及性有限的中低收入国家。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present a case involving a 77-year-old man with prostate cancer who underwent radical prostatectomy with negative surgical margins. After 10 years without follow-up, his serum prostate-specific antigen level increased to 2.76 ng/mL, suggesting disease recurrence. Due to limited access to 68 Ga-PSMA PET/CT, a 99m Tc-HYNIC-PSMA SPECT/CT was conducted, which identified PSMA uptake in the bilateral vas deferens, a rare site for recurrence. While recurrence in the vas deferens has been previously reported using 68 Ga-PSMA PET/CT or PET/MR, this novel experience with 99m Tc-PSMA SPECT/CT highlights its potential utility in detecting such recurrences. This is particularly relevant in low-income countries where access to PET/CT may be limited.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Raeisi N, Saber Tanha A, Sadeghi R, et al. Prostate Adenocarcinoma Recurrence in the Vas Deferens Unveiled by 99m Tc-PSMA SPECT/CT Imaging. Clin Nucl Med. 2025. PMID: 40357624. doi:10.1097/RLU.0000000000005881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。